{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T23:19:00Z","timestamp":1648682340341},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.diagmicrobio.2005.02.012","type":"journal-article","created":{"date-parts":[[2005,6,5]],"date-time":"2005-06-05T11:15:02Z","timestamp":1117970102000},"page":"131-141","source":"Crossref","is-referenced-by-count":2,"title":["Susceptibility testing accuracy of a CTX-M\u2013type extended-spectrum \u03b2-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 \u03b2-lactams"],"prefix":"10.1016","volume":"53","author":[{"given":"Sudha","family":"Pottumarthy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunson","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helio S.","family":"Sader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib1","article-title":"Use of pharmacokinetic-pharmacodynamic and Monte-Carlo simulation as decision support for the re-evaluation of NCCLS cephem susceptibility breakpoints for Enterobacteriaceae","author":"Ambrose","year":"2004"},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.48.1.1-14.2004","article-title":"Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes","volume":"48","author":"Bonnet","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","article-title":"Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat","volume":"14","author":"Bradford","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib4","article-title":"Impact of ESBLs on in vivo activity of four cephalosporins in the neutropenic mouse-thigh infection model","author":"Craig","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib5","article-title":"Experience with ESBL-producing Enterobacteriaceae treated with carbapenems compared to other \u03b2-lactams: outcome report from SENTRY antimicrobial surveillance program","author":"Jones","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2005.02.006","article-title":"Re-evaluation of Enterobacteriaceae MIC\/disk diffusion zone regression scattergrams for nine \u03b2-lactams: adjustments of breakpoints for strains producing extended spectrum \u03b2-lactamases","author":"Jones","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/jac\/dkg312","article-title":"European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria","volume":"52","author":"Kahlmeter","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib8","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1128\/AAC.48.12.4574-4581.2004","article-title":"Bloodstream infections due to extended-spectrum beta-lactamase\u2013producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy","volume":"48","author":"Kang","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib9","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1128\/AAC.46.5.1481-1491.2002","article-title":"Bloodstream infections by extended-spectrum beta-lactamase\u2013producing Escherichia coli and Klebsiella pneumoniae in children: epidemiology and clinical outcome","volume":"46","author":"Kim","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib10","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1128\/AAC.47.7.2382-2383.2003","article-title":"Discovery of CTX-M\u2013like extended-spectrum beta-lactamases in Escherichia coli isolates from five US States","volume":"47","author":"Moland","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ijantimicag.2003.07.004","article-title":"Dissemination of CTX-M type beta-lactamases in Enterobacteriaceae isolates in People's Republic of China","volume":"23","author":"Munday","year":"2004","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib12","series-title":"Approved standard M23-A2","article-title":"Development of in vitro susceptibility testing criteria and quality control parameters","author":"National Committee for Clinical Laboratory Standards","year":"2001"},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib13","series-title":"Approved standard M7-A6","article-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","author":"National Committee for Clinical Laboratory Standards","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib14","series-title":"Document M2-A8","article-title":"Methods for antimicrobial disk susceptibility tests; approved standard","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib15","series-title":"Performance standards for antimicrobial susceptibility testing 15th informational supplement M100-S15","year":"2005"},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib16","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1128\/AAC.48.12.4556-4561.2004","article-title":"Detection of CTX-M\u2013type \u03b2-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru","volume":"48","author":"Pallecchi","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib17","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1128\/JCM.39.6.2206-2212.2001","article-title":"Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum \u03b2-lactamases: implications for the clinical microbiology laboratory","volume":"39","author":"Paterson","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.diagmicrobio.2004.12.004","article-title":"Re-evaluation of the cefepime MIC and disk diffusion test zone diameter relationship for a worldwide collection of Enterobacteriaceae enriched for extended-spectrum-\u03b2-lactamase (ESBL)\u2013producing organisms","author":"Pottumarthy","year":"2005","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3201\/eid0702.010238","article-title":"Controversies about extended-spectrum and AmpC beta-lactamases","volume":"7","author":"Thomson","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1139\/w03-111","article-title":"Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases","volume":"50","author":"Walther-Rasmussen","year":"2004","journal-title":"Can. J. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2005.02.012_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1086\/324742","article-title":"Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime","volume":"34","author":"Wong-Beringer","year":"2002","journal-title":"Clin. Infect. Dis."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889305000519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889305000519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T03:52:35Z","timestamp":1548474755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889305000519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0732889305000519"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2005.02.012","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}